companydata.dkcompanydata.dk

LBN MedTech Ventures ApS: Financial statements 2022

CVR: 39695685

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

LBN MedTech Ventures ApS (CVR 39695685) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,610,817 and a net result of DKK -2,790,408 compared with DKK 6,668 the year before. Equity in the 2022 report amounted to DKK 1,327,976. The solvency ratio was 61.5%. The company had 3 employees in the financial year.

Gross Profit
DKK -1,610,817
Profit/Loss
DKK -2,790,408
Equity
DKK 1,327,976
Total Assets
DKK 2,160,959
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--1.6 mio.-2.8 mio.1.3 mio.3
2021-337 t.7 t.-382 t.1
2020-241 t.-62 t.-388 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on LBN MedTech Ventures ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Flemming Olaf Rosenkrantz leaves the board of LBN MedTech Ventures ApSOct 26, 2022

As of October 26, 2022, Flemming Olaf Rosenkrantz has left the board of directors of LBN MedTech Ventures ApS.

Søren Dige Nørgaard joins LBN MedTech Ventures ApS as adm. dir.Oct 26, 2022

As of October 26, 2022, Søren Dige Nørgaard is registered as adm. dir. of LBN MedTech Ventures ApS.

Flemming Olaf Rosenkrantz steps down as adm. dir. of LBN MedTech Ventures ApSOct 16, 2022

As of October 16, 2022, Flemming Olaf Rosenkrantz has stepped down as adm. dir. of LBN MedTech Ventures ApS.

Lars Braun Nielsen joins the board of LBN MedTech Ventures ApSJun 28, 2022

As of June 28, 2022, Lars Braun Nielsen has joined the board of directors of LBN MedTech Ventures ApS.

LBN MedTech Ventures ApS: The 2021 annual report is outApr 11, 2022

LBN MedTech Ventures ApS has published its annual report for 2021. Gross profit came to DKK 337,084, and the net result was DKK 6,668.

Flemming Olaf Rosenkrantz joins LBN MedTech Ventures ApS as adm. dir.Feb 15, 2022

As of February 15, 2022, Flemming Olaf Rosenkrantz is registered as adm. dir. of LBN MedTech Ventures ApS.

Søren Dige Nørgaard steps down as adm. dir. of LBN MedTech Ventures ApSFeb 15, 2022

As of February 15, 2022, Søren Dige Nørgaard has stepped down as adm. dir. of LBN MedTech Ventures ApS.

Søren Dige Nørgaard joins the board of LBN MedTech Ventures ApSJan 5, 2022

As of January 5, 2022, Søren Dige Nørgaard has joined the board of directors of LBN MedTech Ventures ApS.

Flemming Olaf Rosenkrantz joins the board of LBN MedTech Ventures ApSJan 5, 2022

As of January 5, 2022, Flemming Olaf Rosenkrantz has joined the board of directors of LBN MedTech Ventures ApS.

Lars Juhl joins the board of LBN MedTech Ventures ApSJan 5, 2022

As of January 5, 2022, Lars Juhl has joined the board of directors of LBN MedTech Ventures ApS.

About LBN MedTech Ventures ApS

LBN MedTech Ventures ApS is a Danish company of the type Anpartsselskab based in Aalborg SV, founded in 2018. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named WellB ApS and Mindstep Care ApS. The management consists of Lars Braun Nielsen. The board consists of Lars Braun Nielsen. The company is owned by LBN VISION GOLD ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 401,700 and a net result of DKK -301,979 compared with DKK -2,038,940 the year before. Equity in the 2025 report amounted to DKK -238,641.

Source: annual report 2025, Danish Business Authority

Other financial years